Bhavishya Mittal is the Senior Director of Formulation and Process Development at Kronos Bio (San Mateo, CA), where he leads the strategy for drug product development for all small molecule oncology assets within the company’s portfolio. Bhavi is also an adjunct faculty at the Keck Graduate Institute’s Henry E. Riggs School of Applied Life Sciences (Claremont, CA). Before Kronos, Bhavi worked at AbbVie (Irvine, CA), leading a global CMC team for a BLA-bound molecule. Bhavi has also worked at the US FDA, Takeda, and Astellas Pharmaceuticals. Bhavi has a Ph.D. in Materials Engineering from the Pennsylvania State University and a BS in Chemical Engineering from the National Institute of Technology, Jalandhar (India).
Bhavi has 20+ years of industrial experience in the formulation design, process development, and project management of numerous drug products of small therapeutic molecules (oncology, inflammation, GI, and CNS indications). He is the author of 2 published books on drug product development, 3 granted US patents, 11 peer-reviewed manuscripts, and numerous conference papers and posters presented in various international journals and conferences. His expertise includes product development strategy, project management, outsourcing management, phase-appropriate formulation design (immediate and modified release), process engineering, statistical process control, QbD implementation, FMEA/risk mapping, and process modeling/simulation of unit operations for solid oral dosages.